RECRUITING

Adverse Outcomes and Mortality in Liver Transplant

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Official Title

Adverse Outcomes and Mortality in Liver Transplant

Quick Facts

Study Start:2022-11-02
Study Completion:2026-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05477277

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
  2. 2. Patient clinically indicated for MRI during transplant candidacy evaluation
  3. 3. Adult
  1. 1. Contra indication to MRI

Contacts and Locations

Study Contact

Latasha Bunkley
CONTACT
480.342.5756
bunkley.latasha@mayo.edu

Principal Investigator

Elizabet Carey, MD
PRINCIPAL_INVESTIGATOR
Mayo Cinic

Study Locations (Sites)

Mayo Clinic Arizona
Phoenix, Arizona, 85259
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Elizabet Carey, MD, PRINCIPAL_INVESTIGATOR, Mayo Cinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-02
Study Completion Date2026-07-01

Study Record Updates

Study Start Date2022-11-02
Study Completion Date2026-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • End Stage Liver DIsease
  • Sarcopenia
  • Sarcopenic Obesity
  • Cirrhosis